Frim this day forward docs on the front line will do well to keep in mind and truly practice their 'do no harm' medical ethic. Until the WHO's dismissal of Remdesivir as a 'go to' medical treatment with no practical alternative, every doc was ethically 'in bounds' in choosing or settling on Remdesivir for his or her patients..

That changed today. Thanks to today's DSMB announcement and LL's sterling SAE record, LL's medical efficacy reputation will grow quickly and impressively along side the continuing fail of Remdesivir. Caution Doc! Patience Bunky. JMO.